Glutathione-s-transferase-pi expression in early breast cancer: Association with outcome and response to chemotherapy

Cancer Investigation

Volumn 28, Issue 5, 2010, Pages 554-559

  Arun, Banu K ^a   Granville, Laura A ^b   Yin, Guosheng ^a   Middleton, Lavinia P ^a   Dawood, Shaheenah ^a   Kau, Shu Wan ^a   Kamal, Arif ^a   Hsu, Limin ^a   Hortobagyi, Gabriel N ^a   Sahin, Aysegul A ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Chemotherapy; Lutathione S transferase pi; Prognosis and response predictions

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; GLUTATHIONE TRANSFERASE P1; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; DRUG RESPONSE; DRUG SENSITIVITY; EARLY CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; BRIDGED COMPOUNDS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; TAXOIDS;

EID: 77952127407     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903286925     Document Type: Article

References (28)

1. Armstrong, R.N. Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 1997, 10, 2-18.
2. Perry, R.R.; Mazetta, J.A.; Levin, M.; Barranco, S.C. Glutathione levels and variability n breast tumors and normal tissue. Cancer 1993, 72, 783-787.
3. Williams, J.A.; Phillips, D.H. Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res 2000, 60, 4667-4677.
4. Gilbert, L.; Elwood, L.J.; Merino, M.; et al. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 1993, 11, 49-58.
5. Colovai, A.I.; Stoica, A.; Cinca, S.A.; et al. Glutathione Stransferase activity in human breast tumors. Neoplasma 1992, 39, 249-254.
6. Arai, T.; Miyoshi, Y.; Kim, S.J.; Taguchi, T.; Tamaki, Y.; Noguchi, S. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res Treat 2006, 100, 169-176.
7. Peters, W.H.; Roelofs, H.M.; van Putten, W.L.; Jansen, J.B.; Klijn, J.G.; Foekens, J.A. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br J Cancer 1993, 68, 86-92.
8. Huang, J.; Tan, P.H.; Thiyagarajan, J.; Bay, B.H. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Mod Pathol 2003, 16, 558-565.
9. Perquin, M.; Oster, T.; Maul, A.; Froment, N.; Untereiner, M.; Bagrel, D. The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features. J Cancer Res Clin Oncol 2001, 127, 368-374.
10. Montano, M.M.; Deng, H.; Liu, M.; Sun, X.; Singal, R. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 2004, 23, 2442-2453.
11. Dawling, S.; Hachey, D.L.; Roodi, N.; Parl, F.F. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Chem Res Toxicol 2004, 17, 1258-1264.
12. Schiff, R.; Reddy, P.; Ahotupa, M.; et al. Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo. J Nat Cancer Inst 2000, 92, 1926-1934.
13. Soubeyran, I.; Quenel, N.; Coindre, J.M.; et al. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients. Br J Cancer 1996, 74, 1120-1125.
14. MacGrogan, G.;Mauriac, L.; Durand, M.; et al. Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, cerbB- 2, MiB1, pS2 and GST pi. Br J Cancer 1996, 74, 1458-1465.
15. Kim, R.; Hirabayashi, N.; Nishiyama, M.; Saeki, S.; Toge, T.; Okada, K. Expression of MDR1, GST-pi and topoisomerase II as an indicator of clinical response to adriamycin. Anticancer Res 1991, 11, 429-431.
16. Su, F.; Hu, X.; Jia, W.; Gong, C.; Song, E.; Hamar, P. Glutathion S transferase pi indicates chemotherapy resistance in breast cancer. J Surg Res 2003, 113, 102-108.
17. Wright, C.; Cairns, J.; Cantwell, B.J.; et al. Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases. Br J Cancer 1992, 65, 271-274.
18. Ali-Osman, F.; Brunner, J.M.; Kutluk, T.M.; Hess, K. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas. Clin Cancer Res 1997, 3, 2253-2261.
19. Silvestrini, R.; Veneroni, S.; Benini, E.; et al. Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Nat Cancer Inst 1997, 89, 639-645.
20. Haas, S.; Pierl, C.; Harth, V.; et al. Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. Int J Cancer 2006, 119, 1785-1791.
21. Moureau-Zabotto, L.; Ricci, S.; Lefranc, J.P.; et al. Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients. Br J Cancer 2006, 94, 473-480.
22. Buser, K.; Joncourt, F.; Altermatt, H.J.; Bacchi, M.; Oberli, A.; Cerny, T. Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Ann Oncol 1997, 8, 335-341.
23. Adler, V.; Yin, Z.; Fuchs, S.Y.; et al. Regulation of JNK signaling by GSTp. EMBO J 1999, 18, 1321-1334.
24. Elsby, R.; Kitteringham, N.R.; Goldring, C.E.; et al. Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase Pi. J Biol Chem 2003, 278, 22243-22249.
25. Ruscoe, J.E.; Rosario, L.A.; Wang, T.; et al. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 2001, 298, 339-345.
26. Shen, H.; Kauvar, L.; Tew, K.D. Importance of glutathione and associated enzymes in drug response. Oncol Res 1997, 9, 295-302.
27. Cairns, J.; Wright, C.; Cattan, A.R.; et al. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol 1992, 166, 19-25.
28. Singh, S.V.; Brunnert, S.R.; Roberts, B.; Krishan, A. Differential expression of glutathione S-transferase, glutathione peroxidase and glutathione reductase in normal and malignant human breast tissues. Cancer Lett 1990, 51, 43-48.